Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Deep Cross Linked Hyaluronic Acid for Nasal
Ingredient: 24mg/m hyaluronic acid
Specification: 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml
Package: Syringe
Recommended use: 1-3 pcs, 12 months apart
Application Area: Chin, nasal dorsum, nasal column and anterior nose
Product Introduction：
Double innovation meets clinical versatility: Singlegels achieve seamless tissue fusion through homogeneous matrices, while biphasic gels utilize particle technology for projection enhancement. The 5-tier system spans Super-crosslinked D24+ for deep structural support to Micro D12 for epidermal rejuvenation. Third-party validation shows our products maintain 83% initial volume at 6 months vs 68% in competitor gels, with HD20's chromatic adaptation technology improving lip color congruence by 41%.
Product Display：
Product Details:
Type | Deep |
Ingredient | Cross Linked Hyaluronic Acid Dermal Filler |
Specification | 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml |
Cross Link | BDDE chemical cross link |
Texture | Gel |
Elasticity | 500 Pa-650 Pa |
Viscosity | 150 Pa-250 Pa |
Mean particle size | 400μm-600μm |
Effective content | 24mg/mL |
Cross linker residue | No,or≤0.5ug/g |
Protein residue | ≤20μg/g |
Endotoxin content | <0.5EU/mL |
Swelling degree | 20-40 |
Extruding force | 20N-30N |
Application area | Chin, nasal dorsum, nasal column and anterior nose |
Package | Syringe |
Stoarge | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-3 pcs (vary with each individual |
Recommended interval | 12 month |
Product Package:
Customer Feedback:
Raw Material Advantages：
1. Cross-linking preserves HA's hygroscopic properties while preventing excessive tissue distension through controlled hydration.
2. The stabilized hydrogel structure serves as an optimal scaffold for autologous fat grafting procedures.
Development Process:
Company Introduction:
Driven by innovation, Jinan Grandwill Medical Technology Co., Ltd. (founded 2014) designs medical devices and biomaterials for surgical and aesthetic applications. Our portfolio includes 11 patents, 3 Class III registrations, and 6 production lines operating in GMP-compliant cleanrooms. CE/FDA-aligned quality controls eliminate heavy metals and ensure sterility, positioning us as a trusted partner in clinical safety.
